$Eli Lilly and Co (LLY.US)$ $Novo-Nordisk A/S (NVO.US)$ In the weight loss drug market, Lilly's Tirzepatide (marketed as Zepbound) has officially been approved and is now poised to compete head-to-head with Novo Nordisk's Wegovy. Surprisingly, Lilly has priced Zepbound 20% lower than Wegovy, even though Zepbound is considered to be a more effective product. But why the significant discount?
Two Key Pricing Metrics in the US Drug Industry: List Price and Net Price
Lilly a...

Currently, the major banks in the US are taking a leisurely and sturdy position. This was an unexpected tailwind for major banks because deposits moved from small to medium banks to major banks with higher creditworthiness due to banking system unease last month.
$JPMorgan (JPM.US)$with $Citigroup (C.US)$、 $Wells Fargo & Co (WFC.US)$The three major US banks announced financial results for the fiscal year ending 1-3 months (1st quarter) on the 14th. Both raised profits that exceeded market expectations by several billion yen. $Bank of America (BAC.US)$It also surpassed market expectations in terms of both sales and profit. Sharp questions surrounding the matching of assets and liabilities flew around at the company's financial results briefing.
Each bank expressed concerns about the unstable economic situation and credit crunch, but if interest rates continue to rise, higher interest rate income can be expected from the loan business.
British Financial...